Carlos Costa - Aug 1, 2022 Form 3/A - Amendment Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role
Chief People Officer
Signature
/s /Allan Reine, M.D., Attorney-in-Fact
Stock symbol
FHTX
Transactions as of
Aug 1, 2022
Transactions value $
$0
Form type
3/A - Amendment
Date filed
9/9/2022, 07:38 PM
Date Of Original Report
Aug 3, 2022
Next filing
Jan 30, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding FHTX Stock Options (Right to buy) Aug 1, 2022 Common Stock 75K $14.87 Direct F1, F2
holding FHTX Stock Options (Right to buy) Aug 1, 2022 Common Stock 50K $16.63 Direct F3
holding FHTX Stock Options (Right to buy) Aug 1, 2022 Common Stock 59.5K $8.77 Direct F4
holding FHTX Stock Options (Right to buy) Aug 1, 2022 Common Stock 9.46K $3.72 Direct F2, F5
holding FHTX Stock Options (Right to buy) Aug 1, 2022 Common Stock 89.2K $3.72 Direct F6, F7
holding FHTX Stock Options (Right to buy) Aug 1, 2022 Common Stock 0 $0.73 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the underlying shares of common stock on January 26, 2023, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter until the option is fully vested.
F2 This Form 3/A is being filed to correct the number of stock options that were reported as being beneficially owned in the Form 3 filed on August 3, 2022 (the "Original Form 3").
F3 The option vests as to 25% of the underlying shares of common stock on January 28, 2022, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter until the option is fully vested.
F4 The option vests as to 25% of the underlying shares of common stock on August 17, 2021, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter until the option is fully vested.
F5 The option vests as to 25% of the underlying shares of common stock on January 30, 2020, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter until the option is fully vested.
F6 This Form 3/A is being filed to include these stock options that are held by the reporting person and which were inadvertently omitted from the Original Form 3.
F7 The option vests as to 25% of the underlying shares of common stock on August 29, 2019, and thereafter at a rate of 6.25% of the underlying shares on the first day of each calendar quarter until the option is fully vested.
F8 Due to an administrative error, the Original Form 3 incorrectly reported beneficial ownership of 5,575 stock options with an expiration date of March 27, 2028.

Remarks:

Due to an administrative error, the vesting schedule of each of the awards set forth in Table II was incorrectly described in the Original Form 3. This Form 3/A includes the corrected vesting schedule for each such award. This Form 3/A is also being filed to include the Reporting Person's Power of Attorney as Exhibit 24.